AVNS Avanos Medical, Inc.
Stable Earnings Power
F 30.0 / 100 pillar composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.

Grade overrides the 30.0 pillar composite — hard gates always win.

Profitability

Weight: 20%
F 0
  • 5yr Avg ROIC -6.9%
  • Operating Margin Trend -4.12 pp/yr

Capital Efficiency

Weight: 15%
D- 28
  • 5yr Avg ROE -12.0%
  • 5yr Share-Count CAGR -1.2%

Growth Quality

Weight: 15%
C 55
  • 5yr Revenue CAGR -1.5%
  • 5yr EPS CAGR 723.1%
  • Revenue-Growth Years (5) 3/5

Cash Generation

Weight: 15%
B- 63
  • 5yr FCF Margin 7.9%
  • 5yr FCF/NI Conversion 5.97x

Balance Sheet

Weight: 20%
F 12
  • Net Debt / EBITDA 10.00x
  • Interest Coverage (EBIT/Int) -15.55x
  • Altman Z-Score 2.27

Stability

Weight: 15%
D+ 39
  • EPS Volatility (σ/μ) 0.58
  • Piotroski F-Score 4
  • Negative-Revenue Years (5) 2/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

2 of 2 gurus held; 1 added; 1 trimmed.

Holders
2 +1
Avg Δ position
-44.5%
New buys
0
Full exits
0
As of Q1 2026